VT-109

N/A

Report date: 2025/02/19 16:44:02

Base Information

Drug NameVT-109
Drug Alias NameVT-109
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionB-cell-activating factor/B lymphocyte stimulator inhibitorsTumor necrosis factor ligand superfamily member 13 inhibitors
TargetsB-cell-activating factor/B lymphocyte stimulatorTumor necrosis factor ligand superfamily member 13
Therapy Area/IndicationsLymphatic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesStanford University
China Registration ClassN/A

Develop Information

Active CompaniesVera Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsLymphatic Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A